Manulife (Manufacturers Life Insurance)’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-31,076
| Closed | -$28.4K | – | 2925 |
|
2025
Q1 | $28.4K | Sell |
31,076
-2,535
| -8% | -$2.32K | ﹤0.01% | 2877 |
|
2024
Q4 | $53.4K | Sell |
33,611
-1,501
| -4% | -$2.39K | ﹤0.01% | 2932 |
|
2024
Q3 | $68.8K | Sell |
35,112
-1,377
| -4% | -$2.7K | ﹤0.01% | 2951 |
|
2024
Q2 | $59.8K | Buy |
36,489
+5,244
| +17% | +$8.6K | ﹤0.01% | 2937 |
|
2024
Q1 | $161K | Sell |
31,245
-858
| -3% | -$4.41K | ﹤0.01% | 2672 |
|
2023
Q4 | $184K | Buy |
32,103
+4,135
| +15% | +$23.7K | ﹤0.01% | 2659 |
|
2023
Q3 | $134K | Buy |
27,968
+3,306
| +13% | +$15.8K | ﹤0.01% | 2715 |
|
2023
Q2 | $105K | Buy |
24,662
+2,583
| +12% | +$11K | ﹤0.01% | 2833 |
|
2023
Q1 | $117K | Hold |
22,079
| – | – | ﹤0.01% | 2708 |
|
2022
Q4 | $139K | Buy |
22,079
+108
| +0.5% | +$678 | ﹤0.01% | 2708 |
|
2022
Q3 | $232K | Sell |
21,971
-741
| -3% | -$7.82K | ﹤0.01% | 2490 |
|
2022
Q2 | $123K | Buy |
22,712
+2,163
| +11% | +$11.7K | ﹤0.01% | 2839 |
|
2022
Q1 | $189K | Buy |
20,549
+9,637
| +88% | +$88.5K | ﹤0.01% | 2795 |
|
2021
Q4 | $165 | Buy |
10,912
+1,165
| +12% | +$18 | ﹤0.01% | 2962 |
|
2021
Q3 | $233K | Buy |
+9,747
| New | +$233K | ﹤0.01% | 2873 |
|